Feasibility and efficacy of addition of individualized-dose lenalidomide to chlorambucil and rituximab as first-line treatment in elderly and FCR-unfit patients with advanced chronic lymphocytic leukemia

AP Kater; MHJ van Oers; Yvette van Norden; L Straten; J Driessen; WFM Posthuma; M Schipperus; MED Chamuleau; M Nijland; Jeanette Doorduijn; M Gelder; M Hoogendoorn; F De Croon; S Wittebol; JM Kerst; EWA Marijt; RAP Raymakers; MR Schaafsma; JA Dobber; S Kersting; MD Levin

doi:10.3324/haematol.2018.193854

Feasibility and efficacy of addition of individualized-dose lenalidomide to chlorambucil and rituximab as first-line treatment in elderly and FCR-unfit patients with advanced chronic lymphocytic leukemia

AP Kater, MHJ van Oers, Yvette van Norden, L Straten, J Driessen, WFM Posthuma, M Schipperus, MED Chamuleau, M Nijland, Jeanette Doorduijn, M Gelder, M Hoogendoorn, F De Croon, S Wittebol, JM Kerst, EWA Marijt, RAP Raymakers, MR Schaafsma, JA Dobber, S KerstingMD Levin

Hematology

Research output: Contribution to journal › Article › Academic › peer-review

11 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	147-154
Number of pages	8
Journal	Haematologica
Volume	104
Issue number	1
DOIs	https://doi.org/10.3324/haematol.2018.193854
Publication status	Published - 2019

Research programs

EMC MM-02-41-03

Access to Document

10.3324/haematol.2018.193854

http://hdl.handle.net/1765/115016

Cite this

Kater, AP., van Oers, MHJ., van Norden, Y., Straten, L., Driessen, J., Posthuma, WFM., Schipperus, M., Chamuleau, MED., Nijland, M., Doorduijn, J., Gelder, M., Hoogendoorn, M., De Croon, F., Wittebol, S., Kerst, JM., Marijt, EWA., Raymakers, RAP., Schaafsma, MR., Dobber, JA., ... Levin, MD. (2019). Feasibility and efficacy of addition of individualized-dose lenalidomide to chlorambucil and rituximab as first-line treatment in elderly and FCR-unfit patients with advanced chronic lymphocytic leukemia. Haematologica, 104(1), 147-154. https://doi.org/10.3324/haematol.2018.193854

@article{1341b2679ee549ed9ad3ffa24e1ef56d,

title = "Feasibility and efficacy of addition of individualized-dose lenalidomide to chlorambucil and rituximab as first-line treatment in elderly and FCR-unfit patients with advanced chronic lymphocytic leukemia",

author = "AP Kater and {van Oers}, MHJ and {van Norden}, Yvette and L Straten and J Driessen and WFM Posthuma and M Schipperus and MED Chamuleau and M Nijland and Jeanette Doorduijn and M Gelder and M Hoogendoorn and {De Croon}, F and S Wittebol and JM Kerst and EWA Marijt and RAP Raymakers and MR Schaafsma and JA Dobber and S Kersting and MD Levin",

year = "2019",

doi = "10.3324/haematol.2018.193854",

language = "Undefined/Unknown",

volume = "104",

pages = "147--154",

journal = "Haematologica",

issn = "0390-6078",

publisher = "Ferrata Storti Foundation",

number = "1",

}

Kater, AP, van Oers, MHJ, van Norden, Y, Straten, L, Driessen, J, Posthuma, WFM, Schipperus, M, Chamuleau, MED, Nijland, M, Doorduijn, J, Gelder, M, Hoogendoorn, M, De Croon, F, Wittebol, S, Kerst, JM, Marijt, EWA, Raymakers, RAP, Schaafsma, MR, Dobber, JA, Kersting, S & Levin, MD 2019, 'Feasibility and efficacy of addition of individualized-dose lenalidomide to chlorambucil and rituximab as first-line treatment in elderly and FCR-unfit patients with advanced chronic lymphocytic leukemia', Haematologica, vol. 104, no. 1, pp. 147-154. https://doi.org/10.3324/haematol.2018.193854

Feasibility and efficacy of addition of individualized-dose lenalidomide to chlorambucil and rituximab as first-line treatment in elderly and FCR-unfit patients with advanced chronic lymphocytic leukemia. / Kater, AP; van Oers, MHJ; van Norden, Yvette et al.
In: Haematologica, Vol. 104, No. 1, 2019, p. 147-154.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Feasibility and efficacy of addition of individualized-dose lenalidomide to chlorambucil and rituximab as first-line treatment in elderly and FCR-unfit patients with advanced chronic lymphocytic leukemia

AU - Kater, AP

AU - van Oers, MHJ

AU - van Norden, Yvette

AU - Straten, L

AU - Driessen, J

AU - Posthuma, WFM

AU - Schipperus, M

AU - Chamuleau, MED

AU - Nijland, M

AU - Doorduijn, Jeanette

AU - Gelder, M

AU - Hoogendoorn, M

AU - De Croon, F

AU - Wittebol, S

AU - Kerst, JM

AU - Marijt, EWA

AU - Raymakers, RAP

AU - Schaafsma, MR

AU - Dobber, JA

AU - Kersting, S

AU - Levin, MD

PY - 2019

Y1 - 2019

U2 - 10.3324/haematol.2018.193854

DO - 10.3324/haematol.2018.193854

M3 - Article

C2 - 30115656

SN - 0390-6078

VL - 104

SP - 147

EP - 154

JO - Haematologica

JF - Haematologica

IS - 1

ER -